M. Dolsten

M. Dolsten

Chief Scientific Officer, President, Pfizer Research & DevelopmentatPfizer· In proxies 2013–2024

Pay in FY2022+12% from the year before

M. Dolsten was paid $12.2M in FY2022 (Dec), up 12%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Pfizer proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. PfizerPublic company · 13 yr
    • Chief Scientific Officer, President, Pfizer Research & Development2013 – Present · 13 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?